WHO 2023 data call is now open for antibacterials in the preclinical development pipeline

Developers of traditional and nontraditional agents intended against pathogens on the WHO BPPL and against other medically important pathogens are encouraged to submit their data. 

In January 2020 WHO published its first global analyses of the preclinical antibacterial pipeline, based on publicly available data. The data were primarily gathered through an open data call, with planned annual updates.

This year WHO is collecting information on antimicrobials relevant for AMR including other medically important resistant pathogens, that are not included in the 2017 WHO BPPL.

WHO encourages you to submit data (new or updated) for product(s) to be included in the analyses, using this survey (active from Wednesday 8 March).